In vitro binding properties of 3H-sufentanil, a superior ligand for the mu-opiate receptor
Leysen, J.E.; Gommeren, W.
Archives Internationales de Pharmacodynamie et de Therapie 260(2): 287-289
1982
ISSN/ISBN: 0003-9780 PMID: 6131653 Document Number: 188356
Document emailed within 1 workday
Related Documents
Pasternak, G.W.; Childers, S.R.; Snyder, S.H. 1980: Naloxazone, a long-acting opiate antagonist: effects on analgesia in intact animals and on opiate receptor binding in vitro Journal of Pharmacology and Experimental Therapeutics 214(3): 455-462Daniels, A.J.; Matthews, J.E.; Viveros, O.H.; Leban, J.J.; Cory, M.; Heyer, D. 1995: Structure-activity relationship of novel pentapeptide neuropeptide y receptor antagonists is consistent with a noncontinuous epitope for ligand-receptor binding Molecular Pharmacology 48(3): 425-432
Chukniĭski, P.; Kavardzhikov, V.; Zlatanov, I. 1976: Ligand binding process and regulatory properties of proteins Biofizika 21(6): 1124-1125
Pfeiffer, A.; Herz, A. 1982: Discrimination of three opiate receptor binding sites with the use of a computerized curve-fitting technique Molecular Pharmacology 21(2): 266-271
Homcy, C.J. 1983: The ligand binding assay and its role in understanding adrenergic receptor function Journal of Thoracic and Cardiovascular Surgery 86(2): 193-194
Blanchard, S.G.; Lee, P.H.; Pugh, W.W.; Hong, J.S.; Chang, K.J. 1987: Characterization of the binding of a morphine (mu) receptor-specific ligand: Tyr-Pro-NMePhe-D-Pro-NH2, [3H]-PL17 Molecular Pharmacology 31(4): 326-333
Schneider, R.J.; Atkinson, J.P.; Krause, V.; Kulczycki, A. 1981: Characterization of ligand-binding activity of isolated murine Fc gamma receptor Journal of Immunology 126(2): 735-740
Lanier, B.; Raddatz, R.; Bakthavachalam, V.; Coupry, I.; Neumeyer, J.L.; Lanier, S.M. 1995: Structural and ligand recognition properties of imidazoline binding proteins in tissues of rat and rabbit Molecular Pharmacology 48(4): 703-710
Force, W.R.; Walter, B.N.; Hession, C.; Tizard, R.; Kozak, C.A.; Browning, J.L.; Ware, C.F. 1995: Mouse lymphotoxin-beta receptor. Molecular genetics, ligand binding, and expression Journal of Immunology 155(11): 5280-5288
Powell, M.S.; Barnes, N.C.; Bradford, T.M.; Musgrave, I.F.; Wines, B.D.; Cambier, J.C.; Hogarth, P.Mark. 2006: Alteration of the Fc gamma RIIa dimer interface affects receptor signaling but not ligand binding Journal of Immunology 176(12): 7489-7494
Primus, R.J.; Thurkauf, A.; Xu, J.; Yevich, E.; McInerney, S.; Shaw, K.; Tallman, J.F.; Gallagher, D.W. 1997: II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1 Journal of Pharmacology and Experimental Therapeutics 282(2): 1020-1027
Nakashima, I.; Pu, M.Y.; Nishizaki, A.; Rosila, I.; Ma, L.; Katano, Y.; Ohkusu, K.; Rahman, S.M.; Isobe, K.; Hamaguchi, M. 1994: Redox mechanism as alternative to ligand binding for receptor activation delivering disregulated cellular signals Journal of Immunology 152(3): 1064-1071
Rinken, A. 1995: Subtype-specific changes in ligand binding properties after solubilization of muscarinic receptors from baculovirus-infected Sf9 insect cell membranes Journal of Pharmacology and Experimental Therapeutics 272(1): 8-14
Buranakitjaroen, P.; Kittipawong, P.; Koanantakul, B.; Piamsomboon, C.; Prasassarakich, N.; Silaraks, S.; Sukonthasarn, A.; Tiyapant, A. 2003: Efficacy and safety of rilmenidine, a selective imidazoline I1 receptor binding ligand, in mild-to-moderate Thai hypertensive patients Journal of the Medical Association of Thailand 86(10): 903-910
Melamed, J.; Arnaout, M.A.; Colten, H.R. 1982: Complement (C3b) interaction with the human granulocyte receptor: correlation of binding of fluid-phase radiolabeled ligand with histaminase release Journal of Immunology 128(5): 2313-2318
Lyng, R.; Shur, B.D. 2007: Sperm-egg binding requires a multiplicity of receptor-ligand interactions: new insights into the nature of gamete receptors derived from reproductive tract secretions Society of Reproduction and Fertility Suppl 65: 335-351
Wang, C.D.; Buck, M.A.; Fraser, C.M. 1991: Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists Molecular Pharmacology 40(2): 168-179
Gryzunov, I.A.; Komarova, M.N. 2004: A study of ligand binding to protein using resonance energy transfer from the isoindole fluorescent label to ligand Biofizika 49(6): 979-986
Van Rossum, D.; Ménard, D.P.; Fournier, A.; St-Pierre, S.; Quirion, R. 1994: Binding profile of a selective calcitonin gene-related peptide (CGRP) receptor antagonist ligand, [125I-Tyr]hCGRP8-37, in rat brain and peripheral tissues Journal of Pharmacology and Experimental Therapeutics 269(2): 846-853
Law, P.Y.; Hom, D.S.; Loh, H.H. 1982: Loss of opiate receptor activity in neuroblastoma X glioma NG108-15 hybrid cells after chronic opiate treatment. a multiple-step process Molecular Pharmacology 22(1): 1-4